Early-onset herpes simplex encephalitis type 1 triggered by COVID-19 disease: A case report.
Acyclovir
COVID-19
HSV-1 encephalitis
Reactivation
Vidarabine
Journal
Radiology case reports
ISSN: 1930-0433
Titre abrégé: Radiol Case Rep
Pays: Netherlands
ID NLM: 101467888
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
received:
22
08
2023
revised:
14
11
2023
accepted:
17
11
2023
medline:
8
1
2024
pubmed:
8
1
2024
entrez:
8
1
2024
Statut:
epublish
Résumé
Coronavirus disease 2019 (COVID-19) causes a systemic inflammatory response and a temporary immunosuppression of hosts. Several reports have showed that reactivation of herpes simplex virus type 1 (HSV-1) is strongly associated with COVID-19. We present a case of a 66-year-old female, who developed HSV-1 encephalitis, showing impaired consciousness and typical MRI findings such as hyperintense lesions in the temporal lobe, insular cortices, bilateral medial frontal lobe on diffusion-weighted imaging, 7 days after the onset of COVID-19 symptoms. The number of cases of encephalitis in patients with COVID-19 is increasing. However, there has been limited reports of HSV-1 encephalitis following COVID-19, especially for cases with an interval of 7 days or less from the onset of COVID-19 symptoms to the onset of HSV-1 encephalitis. Our case highlights the importance of considering HSV-1 encephalitis in the differential when managing a patient with COVID-19-associated neurologic complications, even if it is in the early stages of COVID-19.
Identifiants
pubmed: 38188949
doi: 10.1016/j.radcr.2023.11.044
pii: S1930-0433(23)00868-3
pmc: PMC10770472
doi:
Types de publication
Case Reports
Langues
eng
Pagination
855-858Informations de copyright
© 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington.